GlassScriptPhysician profile
Jason Paul Williams
NPI 1689963134
$4,430.79
in general payments reported to CMS, 2019-2025
13 companies · $57.34 in 2025
The $57.34 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,910 · 2020: $79.75 · 2021: $38.67 · 2022: $55.22 · 2023: $152 · 2024: $138 · 2025: $57.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $347.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $3,750.00 | 2019 | |
| Depuy Synthes Sales INC. | $242.83 | 2021-2024 | Orthovisc, Monovisc |
| Medtronic, INC. | $96.17 | 2024-2025 | Intellis Adaptivestim |
| Abbott Laboratories | $89.10 | 2019-2020 | |
| Pacira Therapeutics, INC. | $71.25 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $32.22 | 2019 | |
| Arthrex, INC. | $30.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $27.21 | 2023 | Xarelto |
| Nevro Corp. | $26.00 | 2020 | |
| Spr Therapeutics, INC | $21.46 | 2025 | Sprint Pns System |
| Pacira Pharmaceuticals Incorporated | $15.68 | 2024 | Iovera, Zilretta, Exparel |
| Sanofi-Aventis U.S. LLC | $15.58 | 2023 | |
| Stimwave Technologies Incorporated | $13.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.